Shanghai Haohai Biological Technology Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 1,582.56 million compared to CNY 1,274.8 million a year ago. Revenue was CNY 1,582.56 million compared to CNY 1,274.8 million a year ago.

Net income was CNY 161.75 million compared to CNY 310.5 million a year ago. Basic earnings per share was CNY 0.93 compared to CNY 1.76 a year ago. Diluted earnings per share was CNY 0.93 compared to CNY 1.76 a year ago.